FGF2 and esophageal squamous cell carcinoma: One study discovered that FGF2 overexpression in fibroblasts significantly upregulated depleted T cells by the single-cell sequencing of tissue sources from eight patients with ESCC and that killing T cell toxicity could be improved using the FGFR inhibitor AZD4547 [16].